In the article printed in the January 18th “Primetime” newspaper issue, it’s stated that the emergency medical service is accusing the pharmaceutical company “Aversi” at supplying them with low quality Analgin and Lidocaine ampules.
“Aversi” is a tender-winning company that supplies the emergency-medical center with certain drugs, and is responsible for their quality. The pharmaceutical company doesn’t manufacture the drugs itself, instead purchasing them form “Biopharm.” The emergency-medical service administration even wrote a letter to “Aversi” in order to resolve the issue.
According to the doctors with the emergency-medical service, after responding to a call and showing up, they experience trouble with breaking the Analgin and Lidocaine ampules, finding it overly difficult and failing to administer the medicine on time.
“Aversi” doesn’t deny receiving the letter and the company explains that resolving the issue would entail increasing the price on the medicine purchase, which was unacceptable for the emergency-medical service. On the question of what Aversi plans to do in order to rectify the error, the answer was “nothing.”
Regarding the issue at hand, a comment was made by Maia Bezarashvili, A doctor of the Medical Sciences and the founder of the South Caucasus Doctors’ League:
“I’ve personally used the emergency services recently, but no doctors had any ampule breaking problems. Doctors may types of issues may take place in any country. I believe that the quality of the medicament itself should be controlled first and foremost. However, many European drugs have similar detriments, difficulties in opening and unpackaging them and etc.
There is a requirement for the medicine itself to be of high quality, and we must do everything to ensure that. I’m unaware of the specifics of the quality or who was the manufacturer, I’m not versed in the issue. The Medicine Control Agency should be held responsible for this,” – noted Baia Bezarashvili.
In order to avoid similar instances, experts, medical representatives and politicians are welcoming the increase in medicine quality control and deem the Health Ministry’s initiative to tighten the control quite timely. They are also stating that “Stricter quality control for medicine is an important step forward towards protecting consumers’ rights.”
As a reminder, the quality control for medicine quality is on the rise. The Minister of Health of Georgia, David Sergeenko, made a comment regarding that fact a few days during a government meeting and presented the project regarding the “Government Program of 2016 Covering the Quality Control of Medical Supplies.”
“We have three matters from the Ministry of Health. One of them is for confirming the “Program for the Quality Control of Medical Supplies.” Said program was active during previous years but requires certain modifications that will increase the quality control for the medical supplies. Specifically, it takes into account not just local, but also international, accredited laboratories in the quality-control process.
This process is a long chain and if up until now it only entailed a single check of medicine fresh out of facilities and brought in through export, then now it will be an entire chain that will cover the certification of the raw materials that go in the facilities before being made into medicine. If until now the quality control was selective in the local Samkharauli State Laboratory that hold no international accreditation in this matter, then this year we’ll be adding medicine quality control checks in international European laboratories,” – stared David Sergeenko.